SEC in early stage of probe into Valeant, Ackman pursuit of Allergan

The Securities and Exchange Commission is focused on potential breaches of insider trading laws as Valeant and Bil Ackman seek to buy Allergan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.